Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Mvasi (100mg/4mL) |
| Active Ingredient: | Bevacizumab 25mg/mL |
| Dosage Form: | Concentrate for infusion |
| New Zealand Sponsor: | Amgen New Zealand Limited |
| Manufacturer: | Patheon Manufacturing Services LLC, North Carolina, United States of America |
| Product: | Mvasi (400mg/16mL) |
| Active Ingredient: | Bevacizumab 25mg/mL |
| Dosage Form: | Concentrate for infusion |
| New Zealand Sponsor: | Amgen New Zealand Limited |
| Manufacturer: | Patheon Manufacturing Services LLC, North Carolina, United States of America |
| Product: | Vyvanse |
| Active Ingredient: | Lisdexamfetamine dimesilate 30mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Takeda New Zealand Limited |
| Manufacturers: | Patheon Manufacturing Services LLC, North Carolina, United States of America Patheon Pharmaceuticals Inc, Ohio, United States of America |
| Product: | Vyvanse |
| Active Ingredient: | Lisdexamfetamine dimesilate 50mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Takeda New Zealand Limited |
| Manufacturers: | Patheon Manufacturing Services LLC, North Carolina, United States of America Patheon Pharmaceuticals Inc, Ohio, United States of America |
| Product: | Vyvanse |
| Active Ingredient: | Lisdexamfetamine dimesilate 70mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Takeda New Zealand Limited |
| Manufacturers: | Patheon Manufacturing Services LLC, North Carolina, United States of America Patheon Pharmaceuticals Inc, Ohio, United States of America |
Dated this 29th day of March 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).